George Soros's position in Neurocrine Biosciences is currently worth $22.3 Million. That's 0.74% of their equity portfolio (42nd largest holding). The first Neurocrine Biosciences trade was made in Q4 2010. Since then George Soros bought shares eleven more times and sold shares on nine occasions. The stake costed the investor $17.4 Million, netting the investor a gain of 28% so far.